These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36608594)

  • 21. MicroRNA-101-3p inhibits nasopharyngeal carcinoma cell proliferation and cisplatin resistance through ZIC5 down-regulation by targeting SOX2.
    Li T; Zhang G; Li W; Xiao J; Zhou Z; Tan G; Ai J
    Biol Chem; 2023 Sep; 404(10):961-975. PubMed ID: 36752150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells.
    Cheng Y
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30355645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-577/EIF5A2 axis suppressed the proliferation of DDP-resistant nasopharyngeal carcinoma cells by blocking TGF-β signaling pathway.
    Wu R; Zhong Q; Liu H; Liu S
    Chem Biol Drug Des; 2023 Oct; 102(4):815-827. PubMed ID: 37500510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.
    Li S; Zhang X; Zhang R; Liang Z; Liao W; Du Z; Gao C; Liu F; Fan Y; Hong H
    Cell Cycle; 2017; 16(17):1601-1610. PubMed ID: 28749195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA circRILPL1 promotes nasopharyngeal carcinoma malignant progression by activating the Hippo-YAP signaling pathway.
    Wu P; Hou X; Peng M; Deng X; Yan Q; Fan C; Mo Y; Wang Y; Li Z; Wang F; Guo C; Zhou M; Liao Q; Wang H; Zeng Z; Jiang W; Li G; Xiong W; Xiang B
    Cell Death Differ; 2023 Jul; 30(7):1679-1694. PubMed ID: 37173390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
    Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of USP9X reverses cisplatin resistance by decreasing β-catenin expression in nasopharyngeal carcinoma cells.
    Lu WX; Gan GS; Yang B
    Neoplasma; 2021 Jul; 68(4):810-822. PubMed ID: 34097426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O(6) -methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma.
    Chen SH; Kuo CC; Li CF; Cheung CH; Tsou TC; Chiang HC; Yang YN; Chang SL; Lin LC; Pan HY; Chang KY; Chang JY
    Int J Cancer; 2015 Sep; 137(6):1291-305. PubMed ID: 25693518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial-mesenchymal transition.
    Chen M; Chen C; Luo H; Ren J; Dai Q; Hu W; Zhou K; Tang X; Li X
    Cell Mol Biol Lett; 2020 Nov; 25(1):49. PubMed ID: 33292168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells.
    Feng S; Yang G; Yang H; Liang Z; Zhang R; Fan Y; Zhang G
    Cell Cycle; 2017 May; 16(9):869-878. PubMed ID: 28379054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
    Xia T; Tian H; Zhang K; Zhang S; Chen W; Shi S; You Y
    BMC Cancer; 2021 Sep; 21(1):1003. PubMed ID: 34493236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BarH-like homeobox 2 represses the transcription of keratin 16 and affects Ras signaling pathway to suppress nasopharyngeal carcinoma progression.
    Lu Z; Peng H; Li R; Xu X; Peng J
    Bioengineered; 2022 Feb; 13(2):3122-3136. PubMed ID: 35037835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin reverses the drug resistance of cisplatin in irradiated CNE-1 human nasopharyngeal carcinoma cells through PECAM-1 mediated MRPs down-regulation.
    Sun Y; Chen X; Zhou Y; Qiu S; Wu Y; Xie M; Zhu G; Liang S; Li H; Zhou D; Ju Z; Wang F; Han F; Wang Z; Wang R
    Int J Med Sci; 2020; 17(16):2416-2426. PubMed ID: 33029084
    [No Abstract]   [Full Text] [Related]  

  • 34. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
    Zhao Y; Wang P; Wu Q
    Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pentagalloylglucose suppresses the growth and migration of human nasopharyngeal cancer cells via the GSK3β/β-catenin pathway in vitro and in vivo.
    Fan CW; Tang J; Jiang JC; Zhou MM; Li MS; Wang HS
    Phytomedicine; 2022 Jul; 102():154192. PubMed ID: 35636179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
    Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
    Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma.
    Su C; Li M; Yang Y; Wang Z; Wang Q; Wang W; Ma X; Jie R; Chen H; Li X; Lu J
    Anticancer Agents Med Chem; 2023; 23(17):1944-1957. PubMed ID: 37497684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma.
    Yoshikawa K; Noguchi K; Nakano Y; Yamamura M; Takaoka K; Hashimoto-Tamaoki T; Kishimoto H
    Int J Oncol; 2015; 46(6):2364-70. PubMed ID: 25846049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.